Per- And Polyfluoroalkyl Substances (PFAS) and Public Health Impact: Current Evidence, Emerging Challenges, And Future Perspectives

Authors

Ezeabasili, P. I

School of Science, Federal College of Education (Technical), Umunze (Nigeria)

Ogbuagu, J. O

Faculty of Physical Sciences, Nnamdi Azikiwe University (Nigeria)

Omuku, P. E.

Faculty of Physical Sciences, Nnamdi Azikiwe University (Nigeria)

Chinweuba, N. P.

Faculty of Physical Sciences, Nnamdi Azikiwe University (Nigeria)

Article Information

DOI: 10.47772/IJRISS.2026.100700671

Subject Category: Public Health

Volume/Issue: 10/7 | Page No: 9957-9971

Publication Timeline

Submitted: 2026-07-24

Accepted: 2026-07-29

Published: 2026-08-10

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a large and chemically diverse class of synthetic organofluorine compounds recognized as persistent environmental contaminants because of their exceptional chemical stability, widespread industrial applications, and resistance to biological and environmental degradation. Their extensive use in firefighting foams, food-contact materials, textiles, cosmetics, electronics, and numerous consumer products has resulted in global contamination of water, soil, air, wildlife, and human populations. Biomonitoring studies consistently detect PFAS in human serum worldwide, highlighting widespread exposure and increasing concerns regarding their long-term environmental and public health consequences. This review critically synthesizes current evidence on PFAS chemistry, environmental occurrence, exposure pathways, toxicokinetics, molecular mechanisms of toxicity, public health impacts, regulatory developments, and remediation technologies. A PRISMA-informed narrative review supported by thematic evidence synthesis was undertaken using peer-reviewed literature and authoritative regulatory reports published primarily between 2021 and 2025, while retaining landmark studies that underpin PFAS research. Evidence indicates that contaminated drinking water, dietary intake, occupational activities, indoor dust, and consumer products constitute the principal human exposure pathways. Current epidemiological and toxicological findings associate PFAS exposure with endocrine disruption, hepatotoxicity, immunotoxicity, thyroid dysfunction, metabolic disorders, reproductive and developmental toxicity, cardiovascular disease, neurodevelopmental impairment, reduced vaccine responses, and increased risks of kidney and testicular cancers. However, important uncertainties remain regarding the toxicity of replacement PFAS, mixture effects, chronic low-dose exposure, and limited biomonitoring data from low- and middle-income countries. Although international regulatory initiatives have strengthened PFAS management, disparities in environmental monitoring, policy implementation, quantitative risk assessment, and remediation capacity persist. Future priorities should emphasize harmonized global regulations, expanded biomonitoring, sustainable fluorine-free alternatives, innovative remediation technologies, and integrated public health interventions to reduce PFAS exposure and protect environmental and human health.

Keywords

Per- and polyfluoroalkyl substances (PFAS); environmental contamination; human exposure

Downloads

References

1. Abraham, K., Mielke, H., Fromme, H., Völkel, W., Menzel, J., Peiser, M., & Zepp, F. (2022). Human exposure to per- and polyfluoroalkyl substances from consumer products: A review. Environmental Science: Processes & Impacts, 24(3), 347–365. [Google Scholar] [Crossref]

2. Agency for Toxic Substances and Disease Registry. (2025). Toxicological profile for per- and polyfluoroalkyl substances (PFAS). U.S. Department of Health and Human Services. [Google Scholar] [Crossref]

3. Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., de Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., & van Leeuwen, S. P. J. (2011). Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins. Integrated Environmental Assessment and Management, 7(4), 513–541. https://doi.org/10.1002/ieam.258 [Google Scholar] [Crossref]

4. Cao, Y., Ng, C., Jiang, G., & Li, F. (2022). Molecular mechanisms of PFAS toxicity: Recent advances and future perspectives. Environment International, 166, 107361. [Google Scholar] [Crossref]

5. Conley, J. M., Evans, N., Mash, H., Rosenblum, L., Schenck, K., Glassmeyer, S., & Furlong, E. T. (2021). Comparison of legacy and replacement PFAS in the environment. Environmental Science & Technology, 55(11), 6959–6970. [Google Scholar] [Crossref]

6. Cousins, I. T., Goldenman, G., Herzke, D., Lohmann, R., Miller, M., Ng, C., Patton, S., Scheringer, M., Trier, X., & Wang, Z. (2022). Strategies for managing PFAS as a chemical class. Environmental Science: Processes & Impacts, 24(1), 38–62. [Google Scholar] [Crossref]

7. Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2021). Per- and polyfluoroalkyl substance toxicity and human health: A state-of-the-science review. Toxicological Sciences, 181(1), 1–21. [Google Scholar] [Crossref]

8. Glüge, J., Scheringer, M., Cousins, I. T., DeWitt, J. C., Goldenman, G., Herzke, D., Lohmann, R., Ng, C. A., Trier, X., & Wang, Z. (2020). An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environmental Science: Processes & Impacts, 22(12), 2345–2373. [Google Scholar] [Crossref]

9. Grandjean, P., Andersen, E. W., Budtz-Jørgensen, E., Nielsen, F., Mølbak, K., Weihe, P., & Heilmann, C. (2012). Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307(4), 391–397. [Google Scholar] [Crossref]

10. International Agency for Research on Cancer. (2023). IARC monographs on the identification of carcinogenic hazards to humans: Perfluorooctanoic acid (PFOA). International Agency for Research on Cancer. [Google Scholar] [Crossref]

11. Kurwadkar, S., Dane, J., Kanel, S., Nadagouda, M., Cawdrey, R., Ambade, B., Struckhoff, G., Wilkin, R., & Jha, M. (2022). Per- and polyfluoroalkyl substances in water and wastewater: A review. Journal of Environmental Management, 318, 115626. [Google Scholar] [Crossref]

12. Li, Y., Wang, Z., Zhang, X., & Chen, L. (2024). Global environmental occurrence and distribution of per- and polyfluoroalkyl substances: Recent advances. Science of the Total Environment, 906, 167452. [Google Scholar] [Crossref]

13. Manojkumar, N., Ramasamy, B., & Li, X. (2023). Oxidative stress and mitochondrial dysfunction induced by per- and polyfluoroalkyl substances. Environmental Pollution, 332, 122013. [Google Scholar] [Crossref]

14. OECD. (2021). Reconciling terminology of the universe of per- and polyfluoroalkyl substances (PFAS). Organisation for Economic Co-operation and Development. [Google Scholar] [Crossref]

15. Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical workers. Environmental Health Perspectives, 115(9), 1298–1305. [Google Scholar] [Crossref]

16. Panieri, E., Baralic, K., Djukic-Cosic, D., Buha Djordjevic, A., Saso, L., & Wallace, D. (2022). Environmental occurrence and health implications of per- and polyfluoroalkyl substances. Free Radical Biology and Medicine, 181, 191–202. [Google Scholar] [Crossref]

17. Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019). A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFAS) and present understanding of health effects. Journal of Exposure Science & Environmental Epidemiology, 29(2), 131–147. [Google Scholar] [Crossref]

18. United Nations Environment Programme. (2023). Stockholm Convention on Persistent Organic Pollutants. United Nations Environment Programme. [Google Scholar] [Crossref]

19. United States Environmental Protection Agency. (2024). National Primary Drinking Water Regulations for Per- and Polyfluoroalkyl Substances (PFAS). U.S. Environmental Protection Agency. [Google Scholar] [Crossref]

20. Yang, C., Zhang, H., Liu, X., & Zhao, Y. (2023). Toxicokinetics and tissue distribution of per- and polyfluoroalkyl substances in humans: A systematic review. Critical Reviews in Toxicology, 53(6), 469–489. [Google Scholar] [Crossref]

21. Xing, Y., Liu, J., Chen, Y., & Wang, Z. (2023). Bioaccumulation and trophic transfer of per- and polyfluoroalkyl substances in aquatic food webs. Environmental Pollution, 325, 121397. [Google Scholar] [Crossref]

22. Zhang, Y., Li, X., Chen, J., & Wang, Z. (2025). Emerging per- and polyfluoroalkyl substances: Environmental occurrence, toxicology, and regulatory challenges. Environment International, 194, 108982. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles